Lv3
230 积分 2025-05-28 加入
Proximal Tubulopathy: Prime Mover and Key Therapeutic Target in Diabetic Kidney Disease
13小时前
已完结
Chronic Kidney Disease
26天前
已完结
The ROADMAP trial: olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
1个月前
已完结
Avosentan for Overt Diabetic Nephropathy
1个月前
已完结
Endothelin ETA Receptor Blockade, by Activating ETB Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid Retention
1个月前
已完结
Aldosterone and Aldosterone Modulation in Cardio-Kidney Diseases
1个月前
已完结
Esaxerenone: First Global Approval
1个月前
已完结
Mineralocorticoid receptor (MR) antagonist eplerenone and MR modulator balcinrenone prevent renal extracellular matrix remodeling and inflammation via the MR/proteoglycan/TLR4 pathway
1个月前
已完结
Real-world safety and efficacy of trastuzumab deruxtecan (T-DXd) in patients with HER2-positive/HER2-low metastatic breast cancer: a multicenter retrospective cohort study
1个月前
已完结
Chronic obstructive pulmonary disease
1个月前
已完结
皖公网安备34019202002308
